Literature DB >> 11120762

Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men.

A Falahati-Nini1, B L Riggs, E J Atkinson, W M O'Fallon, R Eastell, S Khosla.   

Abstract

Young adult males who cannot produce or respond to estrogen (E) are osteopenic, suggesting that E may regulate bone turnover in men, as well as in women. Both bioavailable E and testosterone (T) decrease substantially in aging men, but it is unclear which deficiency is the more important factor contributing to the increased bone resorption and impaired bone formation that leads to their bone loss. Thus, we addressed this issue directly by eliminating endogenous T and E production in 59 elderly men (mean age 68 years), studying them first under conditions of physiologic T and E replacement and then assessing the impact on bone turnover of withdrawing both T and E, withdrawing only T, or only E, or continuing both. Bone resorption markers increased significantly in the absence of both hormones and were unchanged in men receiving both hormones. By two-factor ANOVA, E played the major role in preventing the increase in the bone resorption markers, whereas T had no significant effect. By contrast, serum osteocalcin, a bone formation marker, decreased in the absence of both hormones, and both E and T maintained osteocalcin levels. We conclude that in aging men, E is the dominant sex steroid regulating bone resorption, whereas both E and T are important in maintaining bone formation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11120762      PMCID: PMC381474          DOI: 10.1172/JCI10942

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  52 in total

1.  Comparison of serum total calcium, albumin-corrected total calcium, and ionized calcium in 1213 patients with suspected calcium disorders.

Authors:  J Thode; B Juul-Jørgensen; H M Bhatia; M Kjaerulf-Nielsen; P D Bartels; N Fogh-Andersen; O Siggaard-Andersen
Journal:  Scand J Clin Lab Invest       Date:  1989-05       Impact factor: 1.713

2.  Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high-performance liquid chromatography.

Authors:  D Black; A Duncan; S P Robins
Journal:  Anal Biochem       Date:  1988-02-15       Impact factor: 3.365

3.  Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling.

Authors:  J J Stĕpán; M Lachman; J Zvĕrina; V Pacovský; D J Baylink
Journal:  J Clin Endocrinol Metab       Date:  1989-09       Impact factor: 5.958

4.  Menopausal changes in bone remodeling.

Authors:  R P Heaney; R R Recker; P D Saville
Journal:  J Lab Clin Med       Date:  1978-12

5.  Androgen deficiency induces high turnover osteopenia in aged male rats: a sequential histomorphometric study.

Authors:  R G Erben; J Eberle; K Stahr; M Goldberg
Journal:  J Bone Miner Res       Date:  2000-06       Impact factor: 6.741

6.  Cross-sectional versus longitudinal evaluation of bone loss in men and women.

Authors:  L J Melton; S Khosla; E J Atkinson; M K Oconnor; W M Ofallon; B L Riggs
Journal:  Osteoporos Int       Date:  2000       Impact factor: 4.507

7.  Androgen supplementation in eugonadal men with osteoporosis: effects of six months' treatment on markers of bone formation and resorption.

Authors:  F H Anderson; R M Francis; R T Peaston; H J Wastell
Journal:  J Bone Miner Res       Date:  1997-03       Impact factor: 6.741

8.  Differential effects of androgens on cortical bone histomorphometry in gonadectomized male and female rats.

Authors:  R T Turner; G K Wakley; K S Hannon
Journal:  J Orthop Res       Date:  1990-07       Impact factor: 3.494

9.  Marked disparity between trabecular and cortical bone loss with age in healthy men. Measurement by vertebral computed tomography and radial photon absorptiometry.

Authors:  D E Meier; E S Orwoll; J M Jones
Journal:  Ann Intern Med       Date:  1984-11       Impact factor: 25.391

10.  Turnover rate of skeletal alkaline phosphatase in humans.

Authors:  S Posen; H S Grunstein
Journal:  Clin Chem       Date:  1982-01       Impact factor: 8.327

View more
  205 in total

Review 1.  Osteoporosis in men.

Authors:  G M Prelevic
Journal:  J R Soc Med       Date:  2001-12       Impact factor: 5.344

2.  Toremifene to reduce fracture risk in men receiving androgen deprivation therapy for prostate cancer.

Authors:  Matthew R Smith; Ronald A Morton; K Gary Barnette; Paul R Sieber; S Bruce Malkowicz; Domingo Rodriguez; Michael L Hancock; Mitchell S Steiner
Journal:  J Urol       Date:  2010-08-17       Impact factor: 7.450

Review 3.  Effects of hypogonadism on bone metabolism in female adolescents and young adults.

Authors:  Madhusmita Misra
Journal:  Nat Rev Endocrinol       Date:  2012-01-24       Impact factor: 43.330

4.  Musculoskeletal and prostate effects of combined testosterone and finasteride administration in older hypogonadal men: a randomized, controlled trial.

Authors:  Stephen E Borst; Joshua F Yarrow; Christine F Conover; Unyime Nseyo; John R Meuleman; Judyta A Lipinska; Randy W Braith; Darren T Beck; Jeffrey S Martin; Matthew Morrow; Shirley Roessner; Luke A Beggs; Sean C McCoy; Darryl F Cannady; Jonathan J Shuster
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-12-10       Impact factor: 4.310

Review 5.  The pathogenesis, treatment and prevention of osteoporosis in men.

Authors:  Leif Mosekilde; Peter Vestergaard; Lars Rejnmark
Journal:  Drugs       Date:  2013-01       Impact factor: 9.546

Review 6.  Alternative treatment modalities for the hypogonadal patient.

Authors:  Landon W Trost; Mohit Khera
Journal:  Curr Urol Rep       Date:  2014-07       Impact factor: 3.092

Review 7.  The role of estrogen and androgen receptors in bone health and disease.

Authors:  Stavros C Manolagas; Charles A O'Brien; Maria Almeida
Journal:  Nat Rev Endocrinol       Date:  2013-09-17       Impact factor: 43.330

Review 8.  Men, bone and estrogen: unresolved issues.

Authors:  E S Orwoll
Journal:  Osteoporos Int       Date:  2003-03-04       Impact factor: 4.507

Review 9.  Osteoporosis in men.

Authors:  Sundeep Khosla; Shreyasee Amin; Eric Orwoll
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

10.  Gonadal sex steroid status and bone health in middle-aged and elderly European men.

Authors:  D Vanderschueren; S R Pye; K Venken; H Borghs; J Gaytant; I T Huhtaniemi; J E Adams; K A Ward; G Bartfai; F F Casanueva; J D Finn; G Forti; A Giwercman; T S Han; K Kula; F Labrie; M E J Lean; N Pendleton; M Punab; A J Silman; F C W Wu; T W O'Neill; S Boonen
Journal:  Osteoporos Int       Date:  2009-12-15       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.